Fassati A - Search Results

1

Dystrophic phenotype induced in vitro by antibody blockade of muscle alpha-dystroglycan-laminin interaction.

Brown SC, Fassati A, Popplewell L, Page AM, Henry MD, Campbell KP, Dickson G. Brown SC, et al. Among authors: fassati a. J Cell Sci. 1999 Jan;112 ( Pt 2):209-16. doi: 10.1242/jcs.112.2.209. J Cell Sci. 1999. PMID: 9858474

2

Production of high titre helper-free recombinant retroviral vectors by lipofection.

Fassati A, Takahara Y, Walsh FS, Dickson G. Fassati A, et al. Nucleic Acids Res. 1994 Mar 25;22(6):1117-8. doi: 10.1093/nar/22.6.1117. Nucleic Acids Res. 1994. PMID: 8152916 Free PMC article. No abstract available.

3

Efficiency of in vivo gene transfer using murine retroviral vectors is strain-dependent in mice.

Fassati A, Wells DJ, Walsh FS, Dickson G. Fassati A, et al. Hum Gene Ther. 1995 Sep;6(9):1177-83. doi: 10.1089/hum.1995.6.9-1177. Hum Gene Ther. 1995. PMID: 8527476

4

Retroviral-mediated gene transfer into murine and human skeletal muscle for the correction of dystrophin deficiency.

Fassati A, Serpente P, Wells DJ, Walsh FS, Dickson G. Fassati A, et al. Biochem Soc Trans. 1996 May;24(2):275S. doi: 10.1042/bst024275s. Biochem Soc Trans. 1996. PMID: 8736933 No abstract available.

5

Transplantation of retroviral producer cells for in vivo gene transfer into mouse skeletal muscle.

Fassati A, Wells DJ, Walsh FS, Dickson G. Fassati A, et al. Hum Gene Ther. 1996 Mar 20;7(5):595-602. doi: 10.1089/hum.1996.7.5-595. Hum Gene Ther. 1996. PMID: 8845384

6

Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.

Fassati A, Wells DJ, Sgro Serpente PA, Walsh FS, Brown SC, Strong PN, Dickson G. Fassati A, et al. J Clin Invest. 1997 Aug 1;100(3):620-8. doi: 10.1172/JCI119573. J Clin Invest. 1997. PMID: 9239410 Free PMC article.

7

Gene therapy of Duchenne muscular dystrophy.

Fassati A, Murphy S, Dickson G. Fassati A, et al. Adv Genet. 1997;35:117-53. doi: 10.1016/s0065-2660(08)60449-6. Adv Genet. 1997. PMID: 9348647 Review. No abstract available.

8

Retroviral vectors.

Fassati A, Dunckley MG, Dickson G. Fassati A, et al. Mol Cell Biol Hum Dis Ser. 1995;5:1-19. doi: 10.1007/978-94-011-0547-7_1. Mol Cell Biol Hum Dis Ser. 1995. PMID: 9532558 Review. No abstract available.

9

Insertion of two independent enhancers in the long terminal repeat of a self-inactivating vector results in high-titer retroviral vectors with tissue-specific expression.

Fassati A, Bardoni A, Sironi M, Wells DJ, Bresolin N, Scarlato G, Hatanaka M, Yamaoka S, Dickson G. Fassati A, et al. Hum Gene Ther. 1998 Nov 20;9(17):2459-68. doi: 10.1089/hum.1998.9.17-2459. Hum Gene Ther. 1998. PMID: 9853513

10

Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site.

Morgan JE, Gross JG, Pagel CN, Beauchamp JR, Fassati A, Thrasher AJ, Di Santo JP, Fisher IB, Shiwen X, Abraham DJ, Partridge TA. Morgan JE, et al. Among authors: fassati a. J Cell Biol. 2002 May 13;157(4):693-702. doi: 10.1083/jcb.200108047. Epub 2002 May 13. J Cell Biol. 2002. PMID: 12011114 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters